Cargando…
Regional brain volumes relate to Alzheimer’s disease cerebrospinal fluid biomarkers and neuropsychometry: A cross-sectional, observational study
We hypothesized that automated assessment of brain volumes on MRI can predict presence of cerebrospinal fluid abnormal ß-amyloid(42) and Tau protein levels and thus serve as a useful screening test for possible Alzheimer’s disease. 113 participants ranging from cognitively healthy to Alzheimer’s dis...
Autores principales: | Libowitz, Mark R., Wei, Ke, Tran, Thao, Chu, Karen, Moncrieffe, Kristina, Harrington, Michael G., King, Kevin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8297871/ https://www.ncbi.nlm.nih.gov/pubmed/34292973 http://dx.doi.org/10.1371/journal.pone.0254332 |
Ejemplares similares
-
Alzheimer’s Disease: Biomarkers in the Genome, Blood, and Cerebrospinal Fluid
por: Huynh, Rose Ann, et al.
Publicado: (2017) -
Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
por: Dekker, Alain D., et al.
Publicado: (2017) -
Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease
por: Babić, Mirjana, et al.
Publicado: (2014) -
Cerebrospinal fluid neurogranin and YKL‐40 as biomarkers of Alzheimer's disease
por: Janelidze, Shorena, et al.
Publicado: (2015) -
Cerebrospinal Fluid Biomarkers for Early and Differential Alzheimer’s Disease Diagnosis
por: Bjerke, Maria, et al.
Publicado: (2018)